GeorgeBakrisMD

PubMed

• Overview of the Evolution of Hypertension: From Ancient Chinese Emperors to Today.
  Michael A Weber, George L Bakris> ;Hypertension. 2024 Apr 1
• Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
  Pei Paul Lin, Chang Xu, Cindy Chen, Veronica Ashton, Mukul Singhal, George Bakris> ;Journal of Clinical Hypertension. 2024 Mar 24
• Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression.
  Frederick Berro Rivera, Grace Nooriza O Lumbang, Danielle Rose Magno Gaid, Linnaeus Louisse A Cruz, John Vincent Magalong, Nathan Ross B Bantayan, Kyla M Lara-Breiting...> ;Diabetes, Obesity & Metabolism. 2024 Mar 20
• Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials.
  Maria E F Canziani, Rita Birne, Stefan D Anker, Gerasimos Filippatos, Peter Rossing, Luis M Ruilope, Alfredo E Farjat, Peter Kolkhof, Andrea Lage, Meike Brinker, Shwet...> ;BMJ Open. 2024 Mar 19
• Real-world Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
  Chen, C., Campbell, A., Ashton, V., Haskell, L., Singhal, M., Bakris, G.> ;American Journal of Hypertension. 2024 Mar 4
• 1 citations
  RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
  Saxena, M., Gupta, A., Lee, J., Stiglitz, D., Makarova, N., Goyal, N., Guo, W., Zappe, D., , Bakris, G., Chalhoub, F., Desai, A.> ;JAMA. 2024 Mar 5
• Albuminuria is Your Guide to Assessing Future GFR Slope.
  Al Dhaybi, O., Bakris, G.> ;Kidney International Reports. 2024 Feb 1
• 4 citations
  Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
  Agarwal, R., Tu, W., Farjat, A., Farag, Y., Toto, R., Lawatscheck, R., Rohwedder, K., Ruilope, L., Rossing, P., Filippatos, G., Anker, S., , Kaul, S., Pitt, B., Bakris...> ;Annals of Internal Medicine. 2023 Dec 1
• Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials.
  Flack, J., Agarwal, R., Anker, S., Pitt, B., Ruilope, L., Rossing, P., Adler, S., Fried, L., Jamerson, K., Toto, R., Brinker, M., Farjat, A., Kolkhof, P., Lawatscheck,...> ;Kidney Medicine. 2023 Dec 1
• Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
  Ali Ahmed, Stefan D Anker, Javed Butler, George L Bakris, Deepak L Bhatt, Gregg C Fonarow, Milton Packer> ;The Lancet. Diabetes & Endocrinology. 2023 Dec 1
• 1 citations
  Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compare...
  Brendon L Neuen, Hiddo J L Heerspink, Priya Vart, Brian L Claggett, Robert A Fletcher, Clare Arnott, Michael O Falster, Sallie-Anne Pearson, Kenneth W Mahaffey, Bruce ...> ;Circulation. 2024 Feb 6
• Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial.
  Amir Razaghizad, Haya Aziz, Guang K Zhang, João Pedro Ferreira, William B White, Cyrus R Mehta, George L Bakris, Faiez Zannad, Abhinav Sharma> ;Journal of Cardiac Failure. 2023 Nov 7
• Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression.
  Hiddo J L Heerspink, Niels Jongs, Patrick Schloemer, Dustin J Little, Meike Brinker, Christoph Tasto, Martin Karpefors, David C Wheeler, George Bakris, Vlado Perkovic,...> ;Journal of the American Society of Nephrology. 2023 Dec 1
• Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet.
  Kamyar Kalantar-Zadeh, Derek Forfang, George Bakris, Kevin J Martin, Sharon M Moe, Stuart M Sprague> ;Kidney360. 2023 Nov 1
• 4 citations
  Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD Study.
  George L Bakris, Y Fred Yang, James M McCabe, Jin Rong Liu, Xiaojuan J Tan, Vincent J Benn, Bertram Pitt> ;American Journal of Hypertension. 2023 Oct 13
• 1 citations
  Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
  Nikolaos Perakakis, Stefan R Bornstein, Andreas L Birkenfeld, Andreas Linkermann, Münevver Demir, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Lu...> ;Diabetes, Obesity & Metabolism. 2024 Jan 1
• Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis.
  Sylvia E Rosas, Luis M Ruilope, Stefan D Anker, Bertram Pitt, Peter Rossing, Andres Angelo Cadena Bonfanti, Ricardo Correa-Rotter, Fernando González, Carlos Francisco ...> ;Kidney Medicine. 2023 Oct 1
• Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression.
  Sandra C Naaman, George L Bakris> ;Diabetes Care. 2023 Sep 1
• Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
  David B Sacks, Mark Arnold, George L Bakris, David E Bruns, Andrea R Horvath, Åke Lernmark, Boyd E Metzger, David M Nathan, M Sue Kirkman> ;Clinical Chemistry. 2023 Aug 2
• 2 citations
  Slowing the Progression of Diabetic Kidney Disease.
  Olivia Blazek, George L Bakris> ;Cells. 2023 Jul 31
• 7 citations
  Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
  David B Sacks, Mark Arnold, George L Bakris, David E Bruns, Andrea R Horvath, Åke Lernmark, Boyd E Metzger, David M Nathan, M Sue Kirkman> ;Clinical Chemistry. 2023 Aug 2
• 1 citations
  Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
  David B Sacks, Mark Arnold, George L Bakris, David E Bruns, Andrea R Horvath, Åke Lernmark, Boyd E Metzger, David M Nathan, M Sue Kirkman> ;Diabetes Care. 2023 Oct 1
• 9 citations
  Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
  David B Sacks, Mark Arnold, George L Bakris, David E Bruns, Andrea R Horvath, Åke Lernmark, Boyd E Metzger, David M Nathan, M Sue Kirkman> ;Diabetes Care. 2023 Oct 1
• 2 citations
  Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
  George Bakris, Cindy Chen, Alicia K Campbell, Veronica Ashton, Lloyd Haskell, Mukul Singhal> ;Journal of Clinical Hypertension. 2023 Aug 1
• 2 citations
  The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of t...
  Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Liana K Billings, Jennifer B Green, Daisuke Koya, Ofri Mosenzon, Kevin M Pantalone, ...> ;Diabetes, Obesity & Metabolism. 2023 Oct 1
• Join now to see all

Journal Articles

• Ambulatory Blood Pressure Monitoring  
  Tamar S Polonsky, George L Bakris, JAMA
• Special Focus Issue: Blood Pressure Original Investigation Editorial Comment Presence of Diabetes Does Not Mandate Lower Blood Pressure to Reduce Cardiovascular Events∗  
  George L Bakris, Tamar S Polonsky, ScienceDirect
• Reduced Blood Pressure-Lowering Effect of Catheter-Based Renal Denervation in Patients with Isolated Systolic Hypertension: Data from SYMPLICITY HTN-3 and the Global S...  
  Deepak L Bhatt, David Kandzari, Michael Weber, George Bakris, European Heart Journal
• Renal Denervation for Resistant Hypertension and Beyond  
  Laffin LJ, Bakris GL, Adv.Chronic.Kidney Dis, 1/1/2015
• Efficacy and safety of perindopril arginine + amlodipine in hypertension  
  Elliott WJ, Whitmore J, Feldstein JD, Bakris GL, J.Am.Soc.Hypertens, 1/1/2015
• Update on blood pressure goals in diabetes mellitus  
  Laffin LJ, Bakris GL, Curr.Cardiol.Rep, 1/1/2015
• Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease  
  McMullan CJ, Yano Y, Bakris GL, Kario K, Phillips RA, and Forman JP, J.Am.Soc.Hypertens, 1/1/2015
• 12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension: The SYMPLICITY HTN-3 Trial  
  Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen DT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, and Bhatt DL, J.Am.Coll.Cardiol, 1/1/2015
• Endothelin Antagonism and Hypertension: An Evolving Target  
  Laffin LJ, Bakris GL, Semin.Nephrol, 1/1/2015
• Update on blood pressure goals in diabetes mellitus  
  Laffin LJ, Bakris GL, Curr. Cardiol.Rep, 1/1/2015
• Renal Denervation for the Treatment of Resistant Hypertension  
  Iliescu R, Lohmeier TE, Tudorancea I, Laffin L, Bakris GL, Am.J.Physiol Renal Physiol, 1/1/2015
• Hypertension Management in Diabetic Kidney Disease  
  Patney V, Whaley-Connell A, Bakris GL, Diabetes Spectr, 1/1/2015
• Hypertension: Impact of blood pressure lowering in type 2 diabetes  
  Glassock RJ, Bakris GL, Nat Rev.Nephrol, 1/1/2015
• New agents for hyperkalemia  
  Weir MR, Bakris GL, Pitt B, N.Engl.J.Med, 1/1/2015
• New Potassium Binders for the Treatment of Hyperkalemia: Current Data and Opportunities for the Future  
  Pitt B, Bakris GL, Hypertension, 1/1/2015
• Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors  
  Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, and Pitt B, N.Engl.J.Med., 1/1/2015
• Predictors of blood pressure response in the SYMPLICITY HTN-3 trial  
  Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Ro..., Eur.Heart J., 1/1/2015
• Cardiovascular disease in CKD in 2014: New insights into cardiovascular risk factors and outcomes  
  Sarafidis, PA and Bakris GL, Nat.Rev.Nephrol., 1/1/2015
• Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitu...  
  Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Ferreira AC, Pieper A, Kimmeskamp-Kirschbaum N, and B..., Am.J.Nephrol., 1/1/2015
• Renal Denervation for Resistant Hypertension and Beyond  
  Laffin LJ and Bakris GL, Adv.Chronic.Kidney Dis., 1/1/2015
• "Efficacy and safety of perindopril arginine + amlodipine in hypertension"  
  W. J. Elliott, J. Whitmore, J. D. Feldstein, and G. L. Bakris, J.Am.Soc.Hypertens, 1/1/2015
• A clinician's perspective of the role of renal sympathetic nerves in hypertension  
  Briasoulis A and Bakris GL, Front. Physiol., 1/1/2015
• Update on blood pressure goals in diabetes mellitus  
  Laffin, LJ and Bakris GL, Curr.Cardiol.Rep., 1/1/2015
• Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease  
  McMullan CJ, Yano Y, Bakris GL, Kario K, Phillips RA, and Forman JP, J.Am.Soc.Hypertens., 1/1/2015
• A clinician's perspective of the role of renal sympathetic nerves in hypertension  
  Briasoulis A and Bakris GL, Front Physiol, 1/1/2015
• Join now to see all

Books/Book Chapters

• Chronic Kidney Disease and Hypertension 
  Chapter: Changes in guideline trends and applications in practice: JNC 8 and the future 
  Page 1 - 8Yamout S, Bakris GLEditors: Weir MR and Lerma E.Springer Science + Business Media, New York, NY2015
• International Textbook of Diabetes Mellitus 
  Chapter: Arterial hypertension in diabetes: etiology and treatment 
  Page 1079 - 1090Flynn C, Bakris GLEditors: DeFronzo RA, Ferranninni E, and Zimmet P.Wiley & Sons, London, UK2015
• Chronic Renal Disease 
  Chapter: Approach to the Patient with Hypertensive Nephrosclerosis 
  Page 455 - 469Peixoto AJ, Bakris GLEditors: Kimmel P and Rosenberg ME.Elsevier, Academic Press, NY2015
• Heart Failure: A companion to Braunwald's Heart Disease 
  Chapter: Alteration in Kidney Function Associated with Heart Failure 
  Page 233 - 240Polonsky T, Bakris GLEditors: Mann DL and Flecker GM.Elsevier Pub, NY2015
• Clinical Decision Support: Nephrology and Hypertension 
  Chapter: Diabetic Kidney Disease: Hypertension Management 
  Laffin LJ, Singh M, Bakris GLEditors: Himmelfarb J, Linas SL, Tuttle KR.Decision Support in Medicine, LLC, Wilmington, DE2015
• Chronic Kidney Disease and Hypertension 
  Chapter: Changes in guideline trends and applications in practice: JNC 8 and the future. 
  Page 1 - 8Weir MR and Lerma EEditors: Weir MR and Lerma E.Springer Science + Business Media, New York, NY2015
• International Textbook of Diabetes Mellitus 
  Chapter: Arterial hypertension in diabetes: etiology and treatment. 
  Page 1079 - 1090Flynn C and Bakris GLEditors: DeFronzo RA, Ferranninni E, and Zimmet P.Wiley & Sons, London2015
• Chronic Renal Disease 
  Chapter: Approach to the Patient with Hypertensive Nephrosclerosis. 
  Page 455 - 469Peixoto AJ and Bakris GLEditors: Kimmel P and Rosenberg ME.Elsevier, Academic Press, New York2015
• Heart Failure: A companion to Braunwald's Heart Disease 
  Chapter: Alteration in Kidney Function Associated with Heart Failure. 
  Page 233 - 240Polonsky T and Bakris GLEditors: Mann DL and Flecker GM.Elsevier Pub, New YorkEdition 3rd,2015
• Metabolism of Human Diseases 
  Chapter: Hypertension 
  Page 339 - 345Flynn C, Bakris GLEditors: Lammert E and Zeeb M.Springer-Verlag, Wien Heidelberg, Austria2014
• Metabolism of Human Diseases 
  Chapter: Hypertension. 
  Page 339 - 345Flynn C and Bakris GLEditors: Lammert E and Zeeb M.Springer-Verlag, Wien Heidelberg2014
• Atherosclerosis in Clinical Practice 
  Chapter: Treatment of Primary Hypertension 
  Page 129 - 144Briasoulis A, Bakris GLEditors: Bhatt D.Oxford University Press, NY2013
• Decision Support in Medicine. Nephrology & Hypertension 
  Chapter: Diabetic Kidney Disease: Hypertension Management 
  Singh M, Bakris GLEditors: Himmelfarb J, Linas S and Tuttle K.2013
• Atherosclerosis in Clinical Practice 
  Chapter: Treatment of Primary Hypertension. 
  Page 129 - 144Briasoulis A and Bakris GLEditors: Bhatt D.Oxford University Press, New York2013
• Nephrology Secrets 
  Chapter: Primary Hypertension 
  Page 437 - 443Udani S, Bakris GLEditors: Lerma EV and Nissenson AR.Elsevier/Mosby, NY2012
• Improving Management of Hypertension: Reconsidering Efficacy Assessment Springer Healthcare 
  Chapter: Assessment of brachial blood pressure for treatment of hypertension is reaching the target more important than how it is achieved? 
  Page 1 - 10Kalaitzidis RG, Bakris GLEditors: Bakris GL, Bertrand M, Blacher J, S Harrap S, Parati G and Poulter N.2012
• Diabetes and Hypertension: Evaluation and Management 
  Chapter: Antihypertensive therapy and new onset diabetes 
  Page 121 - 128Lazich I, Bakris GLEditors: McFarlane S, Bakris GL,.Humana/Springer Science Media, NY2012
• Diabetes and Hypertension: Evaluation and Management 
  Chapter: Novel pharmacologic approaches in hypertension treatment 
  Page 175 - 184Lerma E, Bakris GLEditors: McFarlane S, Bakris GL,.Humana/Springer Science Media, NY2012
• Evidence-based Management of Diabetes 
  Chapter: Use of dual RAAS blockade in diabetic nephropathy 
  Page 423 - 432Udani S, Bakris GLEditors: Vora J and Buse J.TFM Publishing Ltd., Shrewsbury, UK2012
• Managing the Kidney when the Heart is Failing 
  Chapter: Changes in Kidney Function following Heart Failure Treatment 
  Page 11 - 22Shakaib M, Bakris GLEditors: Bakris GL.Springer Science and Business Media2012
• Managing the Kidney when the Heart is Failing 
  Chapter: Combination Therapy in Hypertension 
  Page 59 - 72Oliva R, Bakris GLEditors: Bakris GL.Springer Science and Business Media2012
• Nephrology Secrets 
  Chapter: Primary Hypertension. 
  Page 437 - 443Udani S and Bakris GLEditors: Lerma EV and Nissenson AR.Elsevier/Mosby, New York2012
• Improving Management of Hypertension: Reconsidering Efficacy Assessment 
  Chapter: Assessment of brachial blood pressure for treatment of hypertension is reaching the target more important than how it is achieved? 
  Page 1 - 10Kalaitzidis RG and Bakris GLEditors: Bakris GL, Bertrand M, Blacher J, S Harrap S, Parati G and Poulter N.Springer Healthcare2012
• Diabetes and Hypertension: Evaluation and Management 
  Chapter: Antihypertensive therapy and new onset diabetes. 
  Page 121 - 128Lazich I and Bakris GLEditors: McFarlane S and Bakris GL.Humana/Springer Science Media, New York2012
• Diabetes and Hypertension: Evaluation and Management 
  Chapter: Novel pharmacologic approaches in hypertension treatment. 
  Page 175 - 184Lerma E and Bakris GLEditors: McFarlane S and Bakris GL.Humana/Springer Science Media, New York2012
• Join now to see all

Lectures

• 2013 Cardiometabolic Health Congress (CMHC) 
  Cardiometabolic Health Congress, Boston, Massachusetts - 10/2/2013
• 2013 Cardiometabolic Health Congress (CMHC) 
  Cardiometabolic Health Congress, Boston, Massachusetts - 10/2/2013
• Nephrology 2012 
  Harvard Medical School, Boston, Massachusetts - 4/22/2012

Other

• Renal Denervation and Intensified Pharmacotherapy Improve True Resistant Hypertension. 
  Bakris GL, Practice Update Website
  http://www.practiceupdate.com/journalscan/14532
  1/3/2015
• Renal Denervation and Intensified Pharmacotherapy Improve True Resistant Hypertension 
  Bakris GL
  http://www.practiceupdate.com/journalscan/14532
  1/3/2015
• "Diabetic Kidney Disease: Hypertension Management in Clinical Decision Support: Nephrology and Hypertension" (edited by Himmelfarb J, Linas SL, Tuttle KR) 
  Laffin LJ, Singh M, B GL, Decision Support in Medicine, LLC
  Wilmington, DE - 1/1/2015
• Complementary Alternative Therapies for Hypertension: Is it worth it? 
  Briasoulis A, Bakris GL, American Heart Association Learning Library
  http://my.americanheart.org/professional/ScienceNews/Complementary-Alternative-Therapies-for-Hypertension-Is-It-Worth-It_UCM_451496_Article.jsp
  1/22/2013
• "Diabetic Kidney Disease: Hypertension Management. IN: Himmelfarb J, Linas S and Tuttle K (Eds.)" 
  Singh M and Bakris GL, Decision Support in Medicine. Nephrology & Hypertension
  https://www.decisionsupportinmedicine.com/DSM/a/program/31
  1/1/2013
• Editor: "Hypertension-Oxford University Press, New York" 
  Baliga RR and Bakris GL
  1/1/2012
• Editor: "Managing the Kidney when the Heart is Failing- Springer Science+Business Media" 
  Bakris GL
  1/1/2012
• Editor: "Improved Management of Hypertension: Reconsidering Efficacy Assessment-Springer Science+ Business Media, France" 
  Bakris GL, Bertrand M, Blacher J, Harrup S, Parati G, Poulter N
  1/1/2012
• Editor: "Diabetes and Hypertension: Evaluation and Management Humana/Springer Science Media, New York" 
  McFarlane S and Bakris GL
  1/1/2012
• Editor: "Chronic Kidney Disease (CKD) and Hypertension Essentials Physicians Press-Jones and Bartlett Learning-Sudbury, MA" 
  Bomback A and Bakris GL
  1/1/2011
• Editor: "The Kidney and Hypertension (2nd ed.) Dunitz Publishing London" 
  BAKRIS, GL
  1/1/2008
• Editor: "The Kidney in Heart Failure IN: Heart Failure Clinics" 
  BAKRIS, GL
  1/1/2008
• Editor: "Managing Diabetic Nephropathy in the Hypertensive Patient nowPharmaLtd." 
  BAKRIS, GL
  1/1/2008
• Editor: "Contemporary Diagnosis and Management of Hypertension and Diabetes. Handbooks in Health Care Co. Newtown, PA" 
  BAKRIS, GL
  1/1/2007
• Editor: "Microalbuminuria: Marker of Kidney and Cardiovascular Disease Current Medicine Group, London" 
  BAKRIS, GL
  1/1/2007
• Editor: "The Kidney in Cardiovascular Disease, Dunitz Publishing" 
  BAKRIS, GL
  1/1/2006
• Editor: "Therapeutic Strategies in Hypertension. Clinical Pub. Oxford, UK" 
  Bakris GL
  1/1/2006
• Editor: "Handbook of Diabetic Hypertension Physicians' Press, Royal Oak, MI" 
  Bell DSH, O'Keefe JH, and Bakris GL
  1/1/2006
• Editor: "Handbook of Hypertension, Science Press, NJ" 
  Lip GYH and Bakris GL
  1/1/2005
• Editor: "Lower Extremity Arterial Disease, Humana Press" 
  Caralis D and Bakris GL
  1/1/2005
• Editor: "The Kidney and Hypertension Dunitz Publishing, London" 
  Bakris GL
  1/1/2003
• Microalbuminuria in type 1 diabetes mellitus 
  Bakris GL, McCulloch DK
  http://www.uptodate.com/contents/microalbuminuria-in-type-1-diabetes-mellitus
  UpToDate, Wolters Kluwer Health - 2012-02-29
• Microalbuminuria in type 2 diabetes mellitus 
  Bakris GL, McCulloch DK
  http://www.uptodate.com/contents/microalbuminuria-in-type-2-diabetes-mellitus
  UpToDate, Wolters Kluwer Health - 2012-02-29
• Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults 
  Bakris GL, Mann JF
  http://www.uptodate.com/contents/antihypertensive-therapy-and-progression-of-nondiabetic-chronic-kid
  UpToDate, Wolters Kluwer Health - 2012-06-28
• Overview of diabetic nephropathy 
  Bakris GL
  http://www.uptodate.com/contents/overview-of-diabetic-nephropathy
  UpToDate, Wolters Kluwer Health - 2012-05-15
• Join now to see all